Publish date: July 1, 2009
By: Cheryl Guttman Krader
Source:

In a pivotal phase III clinical trial, oxybutynin chloride gel 10% (Gelnique) was well tolerated and effective in improving symptoms in women with overactive bladder.
The journal page you requested is now available only to registered Modern Medicine members.